CRBU - Caribou Bioscience GAAP EPS of -$0.46 beats by $0.03 revenue of $3.50M beats by $0.35M May, 09 2023 05:28 PM Caribou Biosciences Inc. 2023-05-09 17:28:13 ET Caribou Bioscience press release ( NASDAQ: CRBU ): Q1 GAAP EPS of -$0.46 beats by $0.03 . Revenue of $3.50M (+31.6% Y/Y) beats by $0.35M . For further details see: Caribou Bioscience GAAP EPS of -$0.46 beats by $0.03, revenue of $3.50M beats by $0.35M